ZBIO Stock Analysis: Buy, Sell, or Hold?
ZBIO - Zenas BioPharma, Inc. Common Stock
$27.23
-0.77 (-2.75%)
βΌ
5d:
+10.38%
30d:
+58.96%
90d:
+33.74%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When ZBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: ZBIO is 15.0% above its trading range ($23.67). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: ZBIO is 15.0% above its trading range ($23.67). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ZBIO is currently trading at $27.23, which is considered extended relative to its 30-day fair value range of $17.00 to $23.67.
Technical Outlook: Technically, ZBIO is in a downtrend. Immediate support is located at $18.72, while resistance sits at $29.25.
Market Sentiment: ZBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.12 (+54.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZBIO is in a downtrend. Immediate support is located at $18.72, while resistance sits at $29.25.
Market Sentiment: ZBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.12 (+54.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.00 -
$23.67
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
ZBIO is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+15.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 54.7% below Wall St target ($42.12)
- WARNING: Recommendation downgraded due to 15.0% overvaluation
Trading Range Analysis
30-Day Trading Range
$17.00 -
$23.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$18.72
Resistance Level
$29.25
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.02
Wall Street Target
$42.13
(+54.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 02, 2026 10:48 PM ET
Data refreshes hourly during market hours. Next update: 11:48 PM
Data refreshes hourly during market hours. Next update: 11:48 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBIO showing a specific setup today?
Insider Activity (6 Months)
9
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Fairmount Funds Managemeβ¦
BUY
150000 shares
2026-03-31
Hongbo Lu
BUY
3768 shares
2026-03-31
Patricia L Allen
BUY
4160 shares
2026-02-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical β¦ |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
Advanced ZBIO Option Strategies
Professional options setups generated by AI based on today's ZBIO price and gamma walls.